secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001104659-23-128084
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura extends $4.67M related-party promissory note maturity to March 31, 2024
-----------------------------------------------------------------------------

- Original note of $4,669,279 at 5.25% interest matured Dec 31, 2023; maturity extended to March 31, 2024.
- Note held by AD Pharma, which owns ~66% of Acura common stock (excluding warrants to purchase 10M shares).
- John Schutte controls AD Pharma and directly owns ~14% of Acura.
- Overdue amounts bear default interest at 7.5%; default triggers include bankruptcy and non-payment.
- Extension provides short-term liquidity relief but highlights ongoing financial pressure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923128084/0001104659-23-128084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923128084/tm2333501d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-128084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer